Where is Today’s Innovation Bottleneck is the second installment of our 4-part series related to a recent statement issued by former FDA Commissioner Scott Gottlieb. Kineticos Founder and CEO, Shailesh Maingi, steers the discussion towards innovation catalysts and deterrents and prompts the panel to shares their insights on how various CRO-Sponsor engagement models play a role in innovation.
- Shailesh Maingi, CEO, Kineticos
- Peter Benton, President & COO, Wordwide Clinical Trials
- Trey Putnam, Professor, Division of Clinical and Translational Sciences, School of Pharmacy, Texas Tech University Health Sciences Center
- Rich Shea, CEO, Eldec Pharmaceuticals
Subscribe to Kineticos to receive weekly emails containing insightful content.